Review





Similar Products

94
ATCC batf ko mice
Batf Ko Mice, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/batf ko mice/product/ATCC
Average 94 stars, based on 1 article reviews
batf ko mice - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

94
Thermo Fisher copy number variation batf hs00924966 cn
Copy Number Variation Batf Hs00924966 Cn, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/copy number variation batf hs00924966 cn/product/Thermo Fisher
Average 94 stars, based on 1 article reviews
copy number variation batf hs00924966 cn - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

97
Thermo Fisher gene exp batf mm00479410 m1
Gene Exp Batf Mm00479410 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp batf mm00479410 m1/product/Thermo Fisher
Average 97 stars, based on 1 article reviews
gene exp batf mm00479410 m1 - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

93
Proteintech 1 ap proteintech
1 Ap Proteintech, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/1 ap proteintech/product/Proteintech
Average 93 stars, based on 1 article reviews
1 ap proteintech - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Cusabio antibodies against batf
<t>BATF</t> in relation to prognosis and sorafenib response in MCHH cohort. ( A ) Boxplot shows the distribution of BATF expression between resistant and sensitive samples. ( B , C <t>)</t> <t>IHC</t> images and BATF-score based on IHC images showing the distribution of BATF expression between sorafenib resistant and sensitive samples (Red arrows: BATF + immune cells; black arrows: BATF- immune cells). ( D ) Paired plot shows the distribution of BATF expression between HCC and paracancer samples. ( E , F ) IHC images and BATF-score based on IHC images shows the distribution of BATF expression between HCC and paracancer samples (Black arrows: immune cells). ( G ) Kaplan-Meier curves of OS with high- and low-BATF expression groups. ( H ) Time-dependent ROC curve of BATF expression analysis for predicting OS at 1-, 2-, and 3-years. ( I ). Univariate and multivariate Cox regression analysis of BATF expression in HCC samples. ( J ) Kaplan-Meier curves of OS with high- and low-BATF score groups. ( K ) Time-dependent ROC curve of BATF-score analysis for predicting OS at 1-, 2-, and 3-years. ( M ) Univariate and multivariate Cox regression analysis of BATF-score expression in HCC samples. MCHH: Mengchao Hepatobiliary Hospital; IHC: Immunohistochemistry; HCC: Hepatocellular carcinoma; OS: Overall survival; ROC: Receiver operating characteristic; *: P < 0.05; **: P < 0.01.
Antibodies Against Batf, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against batf/product/Cusabio
Average 93 stars, based on 1 article reviews
antibodies against batf - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
VectorBuilder GmbH rv-batf orf vectors
<t>BATF</t> in relation to prognosis and sorafenib response in MCHH cohort. ( A ) Boxplot shows the distribution of BATF expression between resistant and sensitive samples. ( B , C <t>)</t> <t>IHC</t> images and BATF-score based on IHC images showing the distribution of BATF expression between sorafenib resistant and sensitive samples (Red arrows: BATF + immune cells; black arrows: BATF- immune cells). ( D ) Paired plot shows the distribution of BATF expression between HCC and paracancer samples. ( E , F ) IHC images and BATF-score based on IHC images shows the distribution of BATF expression between HCC and paracancer samples (Black arrows: immune cells). ( G ) Kaplan-Meier curves of OS with high- and low-BATF expression groups. ( H ) Time-dependent ROC curve of BATF expression analysis for predicting OS at 1-, 2-, and 3-years. ( I ). Univariate and multivariate Cox regression analysis of BATF expression in HCC samples. ( J ) Kaplan-Meier curves of OS with high- and low-BATF score groups. ( K ) Time-dependent ROC curve of BATF-score analysis for predicting OS at 1-, 2-, and 3-years. ( M ) Univariate and multivariate Cox regression analysis of BATF-score expression in HCC samples. MCHH: Mengchao Hepatobiliary Hospital; IHC: Immunohistochemistry; HCC: Hepatocellular carcinoma; OS: Overall survival; ROC: Receiver operating characteristic; *: P < 0.05; **: P < 0.01.
Rv Batf Orf Vectors, supplied by VectorBuilder GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rv-batf orf vectors/product/VectorBuilder GmbH
Average 90 stars, based on 1 article reviews
rv-batf orf vectors - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

93
Proteintech batf
<t>BATF</t> in relation to prognosis and sorafenib response in MCHH cohort. ( A ) Boxplot shows the distribution of BATF expression between resistant and sensitive samples. ( B , C <t>)</t> <t>IHC</t> images and BATF-score based on IHC images showing the distribution of BATF expression between sorafenib resistant and sensitive samples (Red arrows: BATF + immune cells; black arrows: BATF- immune cells). ( D ) Paired plot shows the distribution of BATF expression between HCC and paracancer samples. ( E , F ) IHC images and BATF-score based on IHC images shows the distribution of BATF expression between HCC and paracancer samples (Black arrows: immune cells). ( G ) Kaplan-Meier curves of OS with high- and low-BATF expression groups. ( H ) Time-dependent ROC curve of BATF expression analysis for predicting OS at 1-, 2-, and 3-years. ( I ). Univariate and multivariate Cox regression analysis of BATF expression in HCC samples. ( J ) Kaplan-Meier curves of OS with high- and low-BATF score groups. ( K ) Time-dependent ROC curve of BATF-score analysis for predicting OS at 1-, 2-, and 3-years. ( M ) Univariate and multivariate Cox regression analysis of BATF-score expression in HCC samples. MCHH: Mengchao Hepatobiliary Hospital; IHC: Immunohistochemistry; HCC: Hepatocellular carcinoma; OS: Overall survival; ROC: Receiver operating characteristic; *: P < 0.05; **: P < 0.01.
Batf, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/batf/product/Proteintech
Average 93 stars, based on 1 article reviews
batf - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

Image Search Results


BATF in relation to prognosis and sorafenib response in MCHH cohort. ( A ) Boxplot shows the distribution of BATF expression between resistant and sensitive samples. ( B , C ) IHC images and BATF-score based on IHC images showing the distribution of BATF expression between sorafenib resistant and sensitive samples (Red arrows: BATF + immune cells; black arrows: BATF- immune cells). ( D ) Paired plot shows the distribution of BATF expression between HCC and paracancer samples. ( E , F ) IHC images and BATF-score based on IHC images shows the distribution of BATF expression between HCC and paracancer samples (Black arrows: immune cells). ( G ) Kaplan-Meier curves of OS with high- and low-BATF expression groups. ( H ) Time-dependent ROC curve of BATF expression analysis for predicting OS at 1-, 2-, and 3-years. ( I ). Univariate and multivariate Cox regression analysis of BATF expression in HCC samples. ( J ) Kaplan-Meier curves of OS with high- and low-BATF score groups. ( K ) Time-dependent ROC curve of BATF-score analysis for predicting OS at 1-, 2-, and 3-years. ( M ) Univariate and multivariate Cox regression analysis of BATF-score expression in HCC samples. MCHH: Mengchao Hepatobiliary Hospital; IHC: Immunohistochemistry; HCC: Hepatocellular carcinoma; OS: Overall survival; ROC: Receiver operating characteristic; *: P < 0.05; **: P < 0.01.

Journal: Scientific Reports

Article Title: Immune system development-related signature predicts prognosis and sorafenib-treatment resistance of hepatocellular carcinoma by intergrating machine learning and single-cell analyses

doi: 10.1038/s41598-025-93187-y

Figure Lengend Snippet: BATF in relation to prognosis and sorafenib response in MCHH cohort. ( A ) Boxplot shows the distribution of BATF expression between resistant and sensitive samples. ( B , C ) IHC images and BATF-score based on IHC images showing the distribution of BATF expression between sorafenib resistant and sensitive samples (Red arrows: BATF + immune cells; black arrows: BATF- immune cells). ( D ) Paired plot shows the distribution of BATF expression between HCC and paracancer samples. ( E , F ) IHC images and BATF-score based on IHC images shows the distribution of BATF expression between HCC and paracancer samples (Black arrows: immune cells). ( G ) Kaplan-Meier curves of OS with high- and low-BATF expression groups. ( H ) Time-dependent ROC curve of BATF expression analysis for predicting OS at 1-, 2-, and 3-years. ( I ). Univariate and multivariate Cox regression analysis of BATF expression in HCC samples. ( J ) Kaplan-Meier curves of OS with high- and low-BATF score groups. ( K ) Time-dependent ROC curve of BATF-score analysis for predicting OS at 1-, 2-, and 3-years. ( M ) Univariate and multivariate Cox regression analysis of BATF-score expression in HCC samples. MCHH: Mengchao Hepatobiliary Hospital; IHC: Immunohistochemistry; HCC: Hepatocellular carcinoma; OS: Overall survival; ROC: Receiver operating characteristic; *: P < 0.05; **: P < 0.01.

Article Snippet: IHC staining were performed using the antibodies against BATF (1:15000, CSB-PA619074LA01HU, CUSABIO) as described previously.

Techniques: Expressing, Immunohistochemistry